Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice

Zunino,Susan J.; Storms,David  H.; Newman,John   W.; Pedersen,Theresa  L.; Keen,Carl  L.; Ducore,Jonathan  M.

doi:10.3892/ijo.2012.1650

Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice

Authors:
- Susan J. Zunino
- David H. Storms
- John W. Newman
- Theresa L. Pedersen
- Carl L. Keen
- Jonathan M. Ducore
View Affiliations

Affiliations: United States Department of Agriculture, Agricultural Research Service, Western Human Nutrition Research Center, Davis, CA, USA, Department of Nutrition, University of California Davis, Davis, CA 95616, USA, Department of Pediatrics, Section of Hematology/Oncology, University of California School of Medicine, Sacramento, CA 95817, USA
Published online on: October 4, 2012 https://doi.org/10.3892/ijo.2012.1650
Pages: 2207-2212

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acute lymphoblastic leukemia (ALL) with translocation t(4;11) is a high-risk leukemia found in 60-85% of infants with ALL and is often refractory to conventional chemotherapeutics after relapse. To evaluate the efficacy of dietary resveratrol in vivo, 5-week-old NOD.CB17-Prkdcscid/J mice were fed a control diet or a diet containing 0.2% w/w resveratrol. After 3 weeks of dietary treatment, mice were engrafted with the human t(4;11) ALL line SEM by tail vein injection. Engraftment was monitored by evaluating the presence of human CD19+ cells in peripheral blood using flow cytometry. Relative to control diet, dietary resveratrol did not delay the engraftment of the leukemia cells. To determine if dietary resveratrol could increase efficacy of a chemotherapeutic agent, vincristine was injected intraperitoneally into leukemic mice fed the control or supplemented diet. Survival curves and monitoring the percentage of human leukemia cells in peripheral blood showed that resveratrol did not inhibit leukemia cell growth or influence the activity of vincristine. Mass spectrometric analysis of mouse serum revealed that the majority of resveratrol was present as glucuronidated and sulfated metabolites. These data do not support the concept that dietary resveratrol has potential as a preventative agent against the growth of high-risk t(4;11) ALL.

View Figures

View References

1.	BB AggarwalA BhardwajRS AggarwalNP SeeramS ShishodiaRole of resveratrol in prevention and therapy of cancer: preclinical and clinical studiesAnticancer Res2427832840200415517885
2.	S BanerjeeC Bueso-RamosBB AggarwalSuppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclo-oxygenase 2, and matrix metalloproteinase 9Cancer Res6249454954200212208745
3.	ZG LiT HongY ShimadaI KomotoA KawabeSuppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrolCarcinogenesis2315311536200210.1093/carcin/23.9.153112189197
4.	EO LeeHJ LeeHS HwangKS AhnC ChaePotent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activitiesCarcinogenesis2720592069200610.1093/carcin/bgl05516675471
5.	HS LiuCE PanW YangXM LiuAntitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c miceWorld J Gastroenterol914741476200312854144
6.	L TessitoreA DavitI SarottoG CaderniResveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expressionCarcinogenesis2116191622200010.1093/carcin/21.8.161910910967
7.	SC GuptaR KannappanS ReuterJH KimBB AggarwalChemosensitization of tumors by resveratrolAnn NY Acad Sci1215150160201110.1111/j.1749-6632.2010.05852.x21261654
8.	D ColinE LimagneS JeanningrosA JacquelG LizardEndocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cellsCancer Prev Res410951106201110.1158/1940-6207.CAPR-10-027421467134
9.	G LiS HeL ChangH LuH ZhangGADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrolPhytomedicine187047092011
10.	M KartalG SaydamF SahinY BaranResveratrol triggers apoptosis through ceramide metabolizing genes in human K562 chronic myeloid leukemia cellsNutr Cancer63637644201110.1080/01635581.2011.53848521500096
11.	S FaderlHM KantarjianM TalpazZ EstrovClinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemiaBlood913995401919989596644
12.	MF GreavesJ WiemelsOrigins of chromosome translocations in childhood leukaemiaNat Rev3111200310.1038/nrc1164
13.	J GreilM GramatzkiR BurgerR MarschalekM PeltnerThe acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7Br J Haematol86275283199410.1111/j.1365-2141.1994.tb04726.x8199015
14.	RC StongSJ KorsmeyerJL ParkinDC ArthurJH KerseyHuman acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristicsBlood65213119853917311
15.	B LangeM ValtieriD SantoliD CaraccioloF MavilioGrowth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell linesBlood7019219919873496132
16.	G BaerschT MollersA HotteB Dockhorn-DworniczakC RubeGood engraftment of B-cell precursor ALL in NOD-SCID miceKlin Padiatr209178185199710.1055/s-2008-10439479293448
17.	A BorgmannC BaldyA von StackelbergB BeyermannI FichtnerChildhood ALL blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID micePediatr Hematol Oncol17635650200010.1080/0888001005021134911127395
18.	NLM LiemRA PapaCG MilrossMA SchmidM TajbakhshCharacterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapiesBlood10339053914200410.1182/blood-2003-08-291114764536
19.	RB LockN LiemML FarnsworthCG MilrossC XueThe nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapseBlood9941004108200210.1182/blood.V99.11.4100
20.	BA NijmeijerP MollevangerSL van Zelderen-BholaHC Kluin-NelemansR WillemzeMonitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID miceExp Hematol29322329200110.1016/S0301-472X(00)00669-X11274760
21.	J DörrieH GerauerY WachterSJ ZuninoResveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cellsCancer Res6147314739200111406544
22.	J DörrieK SapalaSJ ZuninoCarnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cellsCancer Lett1703339200111448532
23.	C KellnerSJ ZuninoNitric oxide is synthesized in acute leukemia cells after exposure to phenolic antioxidants and initially protects against mitochondrial membrane depolarizationCancer Lett2154352200410.1016/j.canlet.2004.06.046
24.	JB NachmanHN SatherMG SenselME TriggJM CherlowAugmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapyN Engl J Med33816631671199810.1056/NEJM1998060433823049614257
25.	JA CrowellPJ KorytkoRL MorrisseyTD BoothBS LevineResveratrol-associated renal toxicityToxicol Sci82614619200410.1093/toxsci/kfh26315329443
26.	SJ ZuninoDH StormsJM DucoreNovel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11)Cancer Lett2964954201010.1016/j.canlet.2010.03.01720381955
27.	SJ ZuninoDH StormsJW NewmanTL PedersenCL KeenJM DucoreResveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse modelInt J Oncol4012771284201222200740
28.	VA BrownKR PatelM ViskadurakiJA CrowellM PerloffRepeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axisCancer Res7090039011201010.1158/0008-5472.CAN-10-236420935227
29.	KR PatelE ScottVA BrownAJ GescherWP StewardClinical trials of resveratrolAnn NY Acad Sci1215161169201110.1111/j.1749-6632.2010.05853.x21261655
30.	T WalleF HsiehMH De LeggeJE OatisUK WalleHigh absorption but very low bioavailability of oral resveratrol in humansDrug Metab Dispos3213771382200410.1124/dmd.104.00088515333514
31.	X VitracA DesmouliereB BrouillaudS KrisaG DeffieuxDistribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administrationLife Sci72221922332003
32.	E WenzelT SoldoH ErbersdoblerV SomozaBioactivity and metabolism of trans-resveratrol orally administered to Wistar ratsMol Nutr Food Res49482494200510.1002/mnfr.20050000315779067
33.	JA BaurDA SinclairTherapeutic potential of resveratrol: the in vivo evidenceNat Rev Drug Discov5493506200610.1038/nrd206016732220
34.	Y KimuraH OkudaResveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing miceJ Nutr13118441849200111385077
35.	S BusquetsE AmetllerG FusterM OlivanV RaabResveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer modelCancer Lett245144148200710.1016/j.canlet.2005.12.03516466851
36.	YL WengHF LiaoAF LiJC ChangRY ChiouOral administration of resveratrol in suppression of pulmonary metastasis of BALB/c mice challenged with CT26 colorectal adenocarcinoma cellsMol Nutr Food Res54259267201010.1002/mnfr.20090004919862773
37.	SH KweonJH SongTS KimResveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via down-regulation of MRP1 expressionBiochem Biophys Res Commun395104110201010.1016/j.bbrc.2010.03.14720350534
38.	KB HarikumarAB Kunnumakkara1G SethiP DiagaradjaneP AnandResveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancerInt J Cancer127257268201019908231